EverSource Wealth Advisors’s Pharming Group PHAR Stock Holding History

EverSource Wealth Advisors’s Portfolio PHAR Stock Details PHAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-557	Closed	-$9.27K	–	4515
2026 Q1	$9.27K	Sell	557 -347	-38%	-$5.88K	﹤0.01%	2955
2025 Q4	$16K	Sell	904 -473	-34%	-$7.44K	﹤0.01%	2538
2025 Q3	$20K	Sell	1,377 -1,602	-54%	-$20K	﹤0.01%	2353
2025 Q2	$31.8K	Buy	+2,979	New	+$28.9K	﹤0.01%	1936

Other funds holding PHAR

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

EverSource Wealth Advisors's PHAR Position: Q2 2026 in Review

EverSource Wealth Advisors sold out of Pharming Group (PHAR) in Q2 2026, closing a stake of 557 shares — an estimated $9.27K sold.

EverSource Wealth Advisors first reported a position in PHAR in Q2 2025 and held it in 4 quarters. The position peaked at $31.8K in Q2 2025. 2 funds tracked by Wall St. Rank hold PHAR as of Q2 2026.

EverSource Wealth Advisors reported no remaining Pharming Group position as of Q2 2026 after selling out during the quarter.
EverSource Wealth Advisors sold 557 Pharming Group shares in Q2 2026, an estimated $9.27K.
EverSource Wealth Advisors first reported a position in Pharming Group in Q2 2025 and held it in 4 quarters.
EverSource Wealth Advisors's Pharming Group position peaked at $31.8K in Q2 2025.
2 funds tracked by Wall St. Rank held Pharming Group as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.